Dowling & Yahnke LLC Gilead Sciences, Inc. Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 49,473 shares of GILD stock, worth $4.46 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares

49,473

Previous 47,204 4.81%

Holding current value

$4.46 Million

Previous $2.92 Million 4.59%

% of portfolio

1.42%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$59.54 - $68.01 $135,096 - $154,314	2,269 Added 4.81%	49,473 $3.05 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $49,581 - $55,843	859 Added 1.85%	47,204 $2.92 Million
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $92,266 - $115,619	-1,593 Reduced 3.32%	46,345 $2.76 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $39,771 - $45,141	-613 Reduced 1.26%	47,938 $3.48 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $145,059 - $156,503	2,143 Added 4.62%	48,551 $3.39 Million
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $70,451 - $76,978	1,110 Added 2.45%	46,408 $3.2 Million
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $51,840 - $59,149	864 Added 1.94%	45,298 $2.93 Million
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $140,945 - $160,600	-2,488 Reduced 5.3%	44,434 $2.59 Million
Q3 2020 Oct 19, 2020	SELL	$62.1 - $78.08 $60,050 - $75,503	-967 Reduced 2.02%	46,922 $2.97 Million
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $269,104 - $312,480	3,720 Added 8.42%	47,889 $3.69 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $57,807 - $74,043	-923 Reduced 2.05%	44,169 $3.3 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $152,201 - $167,416	-2,470 Reduced 5.19%	45,092 $2.93 Million
Q3 2019 Oct 29, 2019	SELL	$62.51 - $69.0 $100,578 - $111,021	-1,609 Reduced 3.27%	47,562 $3.01 Million
Q2 2019 Jul 22, 2019	BUY	$61.87 - $69.38 $51,661 - $57,932	835 Added 1.73%	49,171 $3.32 Million
Q1 2019 Apr 30, 2019	SELL	$62.53 - $70.05 $147,133 - $164,827	-2,353 Reduced 4.64%	48,336 $3.14 Million
Q4 2018 Jan 24, 2019	BUY	$60.54 - $79.0 $53,880 - $70,310	890 Added 1.79%	50,689 $3.65 Million
Q3 2018 Oct 30, 2018	SELL	$71.28 - $78.92 $6,557 - $7,260	-92 Reduced 0.18%	49,799 $3.85 Million
Q2 2018 Jul 30, 2018	BUY	$64.88 - $75.68 $2,660 - $3,102	41 Added 0.08%	49,891 $3.53 Million
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $75,170 - $91,641	1,032 Added 2.11%	49,850 $3.76 Million
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $115,618 - $135,720	1,625 Added 3.44%	48,818 $3.5 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $3.4 Million - $4.03 Million	47,193	47,193 $3.82 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Gilead Sciences, Inc. Transaction History